Quarterly Sales Reach $8.7 Billion, Eli Lilly’s Mounjaro Becomes New Blockbuster Drug King May 6, 2026 Life Science
UnitedHealth Soars 36.9% in April, As Earnings Beat Unlocks Valuation Recovery Runway May 5, 2026 Financial Service, Life Science
Eli Lilly’s Alzheimer’s Drug Kisunla Wins Health Canada Approval, Bolstering Global Footprint May 4, 2026 Life Science
Stock Isn’t Cheap but Still Worth Buying? Three Hard Reasons Behind Eli Lilly Explained May 4, 2026 Life Science
Dark Horse in the Weight-Loss Drug Arena? Viking Therapeutics Has Potential Upside of Over 200% May 4, 2026 Life Science
Want to Build Real Wealth in the Healthcare Sector? These Stocks Are Worth Considering Apr 30, 2026 Life Science
How to Invest a $1,000 Tax Refund? Two TSX Stocks Worth Watching Apr 29, 2026 Life Science, Technology
Up 33% Year-to-Date, the Overlooked Retail Dividend Stock Target Finds a Rebound Opportunity Apr 28, 2026 Consumer Goods
From Weight Loss to Cancer Treatment Drugs, Eli Lilly Has More Than One Ace in the Hole Apr 28, 2026 Life Science
Teva Pharmaceuticals to Release Quarterly Report, Analysts Suggest Waiting for Post-Earnings Purchase Apr 27, 2026 Life Science
Buffett’s UnitedHealth Bet Pays Off as Insurer Crushes Q1 Estimates Apr 26, 2026 Financial Service, Life Science
Can the New Weight-Loss Drug Foundayo from Eli Lilly Replicate Its Blockbuster Success? Early Data Raises Market Concerns Apr 25, 2026 Life Science
Aaron Wealth Advisors Increases Stake in MBX Biosciences, Betting on Precision Peptide Therapies for Rare Diseases Apr 23, 2026 Life Science
CVS Health’s Transformation Is Underestimated by the Market, with Three Major Reasons Highlighting Its Value Stock Potential Apr 23, 2026 Life Science
